Literature DB >> 22196845

Hyponatremia and long-term outcomes in chronic heart failure--an observational study from the Duke Databank for Cardiovascular Diseases.

Luca Bettari1, Mona Fiuzat, Linda K Shaw, Daniel M Wojdyla, Marco Metra, G Michael Felker, Christopher M O'Connor.   

Abstract

BACKGROUND: Hyponatremia is a well known predictor of short-term outcomes in heart failure (HF); however, its impact on long-term survival in HF patients with systolic dysfunction is not well established. METHODS AND
RESULTS: Using the Duke Databank for Cardiovascular Diseases, we identified 1,045 patients with HF and systolic dysfunction undergoing cardiac catheterization from January 2000 through December 2008. The effect of hyponatremia as independent predictor of all-cause death and cardiovascular death/rehospitalization was examined using a multivariable Cox proportional regression model. Hyponatremia was present in 107/1,045 patients (10.2%). Hyponatremic patients were older, more likely to be anemic, with higher heart rate and levels of blood urea nitrogen, lower blood pressure, and more severe HF. Using an unadjusted analysis, hyponatremia was associated with higher risk of all-cause death (hazard ratio [HR] 1.89, 95% confidence interval [CI] 1.44-2.49; P < .0001) and of cardiovascular death/rehospitalization (HR 1.40, 95% CI 1.11-1.77; P = .005) at 4.5 years. When entered into a multivariable Cox model, hyponatremia remained significant for all-cause death (HR 1.42, 95% CI 1.07-1.88) and for cardiovascular death/rehospitalization (HR 1.45, 95% CI 1.14-1.86).
CONCLUSIONS: Hyponatremia is relatively common in HF patients with LV dysfunction and is independently associated with increased risk of all-cause mortality and cardiovascular mortality/rehospitalization.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22196845     DOI: 10.1016/j.cardfail.2011.09.005

Source DB:  PubMed          Journal:  J Card Fail        ISSN: 1071-9164            Impact factor:   5.712


  17 in total

1.  Relationship and mechanism of Kv2.1 expression to ADH secretion in rats with heart failure.

Authors:  Jiaxiang Li; Baiyun Tang; Wenbo Zhang; Cuiping Wang; Song Yang; Bao Zhang; Xiuren Gao
Journal:  Am J Transl Res       Date:  2017-08-15       Impact factor: 4.060

2.  Approach to hyponatremia according to the clinical setting: Consensus statement from the Italian Society of Endocrinology (SIE), Italian Society of Nephrology (SIN), and Italian Association of Medical Oncology (AIOM).

Authors:  E Sbardella; A M Isidori; G Arnaldi; M Arosio; C Barone; A Benso; R Berardi; G Capasso; M Caprio; F Ceccato; G Corona; S Della Casa; L De Nicola; M Faustini-Fustini; E Fiaccadori; L Gesualdo; S Gori; A Lania; G Mantovani; P Menè; G Parenti; C Pinto; R Pivonello; P Razzore; G Regolisti; C Scaroni; F Trepiccione; A Lenzi; A Peri
Journal:  J Endocrinol Invest       Date:  2017-11-20       Impact factor: 4.256

Review 3.  Hyponatraemia: more than just a marker of disease severity?

Authors:  Robert W Schrier; Shailendra Sharma; Dmitry Shchekochikhin
Journal:  Nat Rev Nephrol       Date:  2012-11-20       Impact factor: 28.314

4.  Hyponatremia in the outpatient setting: clinical characteristics, risk factors, and outcome.

Authors:  Vildan Tasdemir; Ali Kemal Oguz; Irmak Sayın; Ihsan Ergun
Journal:  Int Urol Nephrol       Date:  2015-10-22       Impact factor: 2.370

5.  Hyponatremia, mineral metabolism, and mortality in incident maintenance hemodialysis patients: a cohort study.

Authors:  Sagar U Nigwekar; Julia Wenger; Ravi Thadhani; Ishir Bhan
Journal:  Am J Kidney Dis       Date:  2013-04-13       Impact factor: 8.860

Review 6.  Hyponatremia in patients with heart failure.

Authors:  Theodosios D Filippatos; Moses S Elisaf
Journal:  World J Cardiol       Date:  2013-09-26

7.  Pre-dialysis serum sodium and mortality in a national incident hemodialysis cohort.

Authors:  Connie M Rhee; Vanessa A Ravel; Juan Carlos Ayus; John J Sim; Elani Streja; Rajnish Mehrotra; Alpesh N Amin; Danh V Nguyen; Steven M Brunelli; Csaba P Kovesdy; Kamyar Kalantar-Zadeh
Journal:  Nephrol Dial Transplant       Date:  2015-09-25       Impact factor: 5.992

Review 8.  Vasopressin receptor antagonists for the treatment of heart failure: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Ionut Nistor; Iris Bararu; Maria-Cristina Apavaloaie; Luminita Voroneanu; Mihaela-Dora Donciu; Mehmet Kanbay; Evi V Nagler; Adrian Covic
Journal:  Int Urol Nephrol       Date:  2014-10-04       Impact factor: 2.370

9.  Patient and medication-related factors associated with hospital-acquired hyponatremia in patients hospitalized from heart failure.

Authors:  S Saepudin; Patrick A Ball; Hana Morrissey
Journal:  Int J Clin Pharm       Date:  2016-04-04

10.  Hyponatremia during hospitalization and in-hospital mortality in patients hospitalized from heart failure.

Authors:  S Saepudin; Patrick A Ball; Hana Morrissey
Journal:  BMC Cardiovasc Disord       Date:  2015-08-14       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.